NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$5.1b

Last Updated

2021/04/19 23:24 UTC

Data Sources

Company Financials +

Executive Summary

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. More Details


Snowflake Analysis

Flawless balance sheet with proven track record.


Similar Companies

Share Price & News

How has Exponent's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: EXPO is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: EXPO's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

-2.9%

EXPO

1.6%

US Professional Services

1.3%

US Market


1 Year Return

37.2%

EXPO

42.7%

US Professional Services

53.8%

US Market

Return vs Industry: EXPO underperformed the US Professional Services industry which returned 42.7% over the past year.

Return vs Market: EXPO underperformed the US Market which returned 53.9% over the past year.


Shareholder returns

EXPOIndustryMarket
7 Day-2.9%1.6%1.3%
30 Day3.6%6.7%5.1%
90 Day3.6%8.1%8.9%
1 Year38.5%37.2%43.9%42.7%56.6%53.8%
3 Year137.4%130.7%67.5%62.7%64.4%53.6%
5 Year321.6%299.1%140.1%123.3%120.4%95.7%

Long-Term Price Volatility Vs. Market

How volatile is Exponent's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Exponent undervalued compared to its fair value and its price relative to the market?

62.8x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: EXPO ($100.86) is trading above our estimate of fair value ($53.13)

Significantly Below Fair Value: EXPO is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: EXPO is poor value based on its PE Ratio (64x) compared to the US Professional Services industry average (29x).

PE vs Market: EXPO is poor value based on its PE Ratio (64x) compared to the US market (22.5x).


Price to Earnings Growth Ratio

PEG Ratio: EXPO is poor value based on its PEG Ratio (6.9x)


Price to Book Ratio

PB vs Industry: EXPO is overvalued based on its PB Ratio (14.5x) compared to the US Professional Services industry average (3.3x).


Future Growth

How is Exponent forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

9.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EXPO's forecast earnings growth (9.3% per year) is above the savings rate (2%).

Earnings vs Market: EXPO's earnings (9.3% per year) are forecast to grow slower than the US market (18% per year).

High Growth Earnings: EXPO's earnings are forecast to grow, but not significantly.

Revenue vs Market: EXPO's revenue (9.6% per year) is forecast to grow faster than the US market (9.3% per year).

High Growth Revenue: EXPO's revenue (9.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if EXPO's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Exponent performed over the past 5 years?

15.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: EXPO has high quality earnings.

Growing Profit Margin: EXPO's current net profit margins (21.8%) are higher than last year (21.1%).


Past Earnings Growth Analysis

Earnings Trend: EXPO's earnings have grown by 15.2% per year over the past 5 years.

Accelerating Growth: EXPO's earnings growth over the past year (0.2%) is below its 5-year average (15.2% per year).

Earnings vs Industry: EXPO earnings growth over the past year (0.2%) underperformed the Professional Services industry 1.4%.


Return on Equity

High ROE: EXPO's Return on Equity (22.8%) is considered high.


Financial Health

How is Exponent's financial position?


Financial Position Analysis

Short Term Liabilities: EXPO's short term assets ($366.8M) exceed its short term liabilities ($117.3M).

Long Term Liabilities: EXPO's short term assets ($366.8M) exceed its long term liabilities ($101.3M).


Debt to Equity History and Analysis

Debt Level: EXPO is debt free.

Reducing Debt: EXPO has not had any debt for past 5 years.

Debt Coverage: EXPO has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: EXPO has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Exponent current dividend yield, its reliability and sustainability?

0.81%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: EXPO's dividend (0.79%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.24%).

High Dividend: EXPO's dividend (0.79%) is low compared to the top 25% of dividend payers in the US market (3.46%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, EXPO has been paying a dividend for less than 10 years.

Growing Dividend: EXPO's dividend payments have increased, but the company has only paid a dividend for 8 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (48.2%), EXPO's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: EXPO's dividends in 3 years are forecast to be well covered by earnings (48.8% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

19.4yrs

Average management tenure


CEO

Catherine Corrigan (51 yo)

2.92yrs

Tenure

US$2,607,550

Compensation

Dr. Catherine Ford Corrigan, Ph. D., PE, has been the President of Exponent Inc. since July 29, 2016 and its Chief Executive Officer and Director since May 31, 2018. She served as Group Vice President of T...


CEO Compensation Analysis

Compensation vs Market: Catherine's total compensation ($USD2.61M) is below average for companies of similar size in the US market ($USD6.51M).

Compensation vs Earnings: Catherine's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: EXPO's management team is seasoned and experienced (19.4 years average tenure).


Board Members

Experienced Board: EXPO's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: EXPO insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Exponent, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Exponent, Inc.
  • Ticker: EXPO
  • Exchange: NasdaqGS
  • Founded: 1967
  • Industry: Research and Consulting Services
  • Sector: Commercial Services
  • Market Cap: US$5.127b
  • Shares outstanding: 51.80m
  • Website: https://www.exponent.com

Number of Employees


Location

  • Exponent, Inc.
  • 149 Commonwealth Drive
  • Menlo Park
  • California
  • 94025
  • United States

Listings


Biography

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory complian...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/19 23:24
End of Day Share Price2021/04/19 00:00
Earnings2021/01/01
Annual Earnings2021/01/01


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.